2026-08-20 Company Bull
AI and mRNA Cancer Vaccine News Drive ARKG to New High Multiple sources confirm ARKG new high, with mRNA cancer vaccine and Anthropic partnership catalyzing genomics theme
D1 -0.2% · +5d +4.7%
2026-08-11 Other Bull
ARKG Hits 52-Week High, Slightly Pulls Back; Multiple Sources Confirm Uptrend Multiple independent technical analysts confirm ARKG's new primary uptrend, breaking to 52-week highs
D1 +0.5% · +5d -3.0%
› 2 waves of this story2026-08-11 Multiple independent analysts see the genomics ETF breaking out of a long base, with market repricing2026-08-11 Multiple independent technical analysts confirm ARKG's new primary uptrend, breaking to 52-week highs1 earlier events › 2026-06-25 → 07-02 Other Bull
ARKG Backed by 73% YoY Surge in Global Biotech Fund Flows Flow data independently corroborates prior AI-healthcare narrative, reinforcing sector capital support
D1 +4.0% · +5d +7.0%
› 4 waves of this story2026-06-25 Multiple independent sources confirm ARKG breakout to 4-year highs, with holdings like ILMN showing technical breakouts, indicating strength in genomics theme.2026-06-26 Multiple analysts highlight breakout pattern alongside elevated short interest, drawing market attention2026-06-27 Multiple independent sources cite ARKG strength and genomic AI trend, reinforcing prior high event2026-07-02 Flow data independently corroborates prior AI-healthcare narrative, reinforcing sector capital supportby direction · sourced
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
be the first
🙂 Post
Facts and opinions separated · All items sourced · Not investment advice
